Polysaccharide hydrogels for skin wound healing
M Liu, J Jin, X Zhong, L Liu, C Tang, L Cai - Heliyon, 2024 - cell.com
Advances in the development and utilization of polysaccharide materials are highly
promising, offering prominent applications in the field of tissue engineering for addressing …
promising, offering prominent applications in the field of tissue engineering for addressing …
HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6: a systematic review and meta-analysis
S Katelani, GE Fragoulis, AD Bakasis… - …, 2023 - academic.oup.com
Objective The objective of this study was to assess the possibility of HBV reactivation (HBVr)
in patients with RA under anti-IL-6 treatment. Methods Using PubMed, Scopus and …
in patients with RA under anti-IL-6 treatment. Methods Using PubMed, Scopus and …
Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS‐CoV‐2 Omicron infection
WWY Tso, MYW Kwan, JSY Kwok… - Journal of Medical …, 2023 - Wiley Online Library
Omicron generally causes milder disease than previous strains of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), especially in fully vaccinated individuals. However …
syndrome coronavirus 2 (SARS‐CoV‐2), especially in fully vaccinated individuals. However …
Bioinspired asymmetric double-layer dressings for stepwise treatment of hemorrhagic wounds
Although various dressings have been developed for wound healing, ideal dressings are
still lacking to meet the requirements of coordinated hemostasis and angiogenesis for the …
still lacking to meet the requirements of coordinated hemostasis and angiogenesis for the …
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping
H Tanaka, Y Okada, S Nakayamada… - Annals of the …, 2024 - ard.bmj.com
Objective Extracting immunological and clinical heterogeneity across autoimmune
rheumatic diseases (AIRDs) is essential towards personalised medicine. Methods We …
rheumatic diseases (AIRDs) is essential towards personalised medicine. Methods We …
Interleukin-6 drives endothelial glycocalyx damage in COVID-19 and bacterial sepsis
CC Drost, A Rovas, I Osiaevi, K Schughart, A Lukasz… - Angiogenesis, 2024 - Springer
Damage of the endothelial glycocalyx (eGC) plays a central role in the development of
vascular hyperpermeability and organ damage during systemic inflammation. However, the …
vascular hyperpermeability and organ damage during systemic inflammation. However, the …
[HTML][HTML] Перспективы ингибиции интерлейкина-6 при ревматоидном артрите: олокизумаб (новые моноклональные антитела к ИЛ-6)
ЕЛ Насонов, Е Файст - Научно-практическая ревматология, 2022 - cyberleninka.ru
Ревматоидный артрит (РА)-хроническое иммуновоспалительное ревматическое
заболевание (ИВРЗ), проявляющееся прогрессирующей деструкцией суставов …
заболевание (ИВРЗ), проявляющееся прогрессирующей деструкцией суставов …
Successfully treated with siltuximab and prednisone in a 7-year-old girl with DOCK8-deficiency presenting as recurrent wart-like lesions: a case report
Z Sun, R Wei, C Pan, C Ni, X Zhang, W Guan… - Frontiers in …, 2024 - frontiersin.org
Dedicator of cytokinesis 8 (DOCK8) deficiency represents a primary immunodeficiency with
a wide range of clinical symptoms, including recurrent infections, atopy, and increased …
a wide range of clinical symptoms, including recurrent infections, atopy, and increased …
Фармакотерапия гигантоклеточного артериита и ревматической полимиалгии: перспективы применения моноклональных антител к интерлейкину 6
ЕЛ Насонов, АМ Сатыбалдыев… - Научно …, 2024 - rsp.mediar-press.net
Аннотация Гигантоклеточный артериит (ГКА) и ревматическая полимиалгия (РПМ)–
иммуновоспалительные ревматические заболевания (ИВРЗ), особенностью которых …
иммуновоспалительные ревматические заболевания (ИВРЗ), особенностью которых …
The latest advances in the use of biological DMARDs to treat Still's disease
I Di Cola, P Ruscitti - Expert Opinion on Biological Therapy, 2024 - Taylor & Francis
Introduction Currently, the therapeutic management of Still's disease, a multisystemic
inflammatory rare disorder, is directed to target the inflammatory symptoms and signs of …
inflammatory rare disorder, is directed to target the inflammatory symptoms and signs of …